Project Grant HT94252410984
Award Date
11/1/24
Completion Date
10/31/26
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
This federal Project Grant award of $2,200,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the public, with a specific focus on investigating the efficacy of tranexamic acid to reduce capillary leak, tissue edema, and fluid resuscitation requirements after severe burn injury. The award was...
The U.S. Defense Health Agency awarded a $1,965,204 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Washington to support the early-stage development of an anti-inflammatory melanocortin fusion protein for tactical combat casualty care. The award period runs from August 1, 2024 to July 31, 2027. This research aims to investigate new therapeutic approaches for improving health outcomes for military service members. As a prominent...
The Cooperative Agreement award of $1,987,608.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support the Metis Foundation in improving severe burn resuscitation outcomes through the use of icatibant, an FDA-approved bradykinin B2 receptor antagonist. This 2-year project, running from September 2023 to September 2025, aims to develop innovative medical technologies and conduct research to transform care for military service members...
The federal Project Grant award of $5,099,737.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a myeloid-targeted novel therapeutic for glomerular diseases. The award, with a performance period from July 1, 2025 to June 30, 2029, was granted to 149 Bio LLC, a for-profit organization located in Miami, Florida. The funded research aims to transform healthcare for military service members, veterans, and the broader public...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,217,668.00 to the Medstar Health Research Institute Inc. for a research project titled "Toxic Products of Combustion in Burn and Smoke Inhalation Injuries". The performance period runs from September 1, 2024 through October 31, 2027. The Medstar Health Research Institute Inc., a non-profit healthcare research organization, will conduct...
This Project Grant award of $2,209,988.00 from the Defense Health Agency supports research by The Leland Stanford Junior University, doing business as Stanford University, to develop pharmacological approaches for protection and recovery from burn-associated inhalation injury. The research is funded under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for service members and the public. Over the award period from...
This $1,189,653 Project Grant was awarded by the Defense Health Agency to Wake Forest University Health Sciences on August 1, 2023 under the Military Medical Research and Development program (CFDA 12.420). The purpose of the grant is to develop a stable and effective off-the-shelf wound care treatment for combat burn injuries. Wake Forest University Health Sciences, an academic medical center, will conduct the research and development work over a 3-year period ending on July 31, 2026. As a...
This federal Project Grant award, totaling $3,602,532.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award supports the development of a sustained-release drug delivery device to manage biofilm implant-related infections in the spine and lateral femur. The primary awardee is the University of Utah, which has a strong track record of executing complex medical research projects for federal agencies. The...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,199,936.00 to the University of California, Davis to develop a point-of-care, scalable, long-acting nanoparticle anesthetic tilapia dressing for burn wound and pain management. The award period runs from July 1, 2025 to June 30, 2028. The University of California, Davis, a prominent public research university, will leverage its extensive scientific...
The University of Florida was awarded a $1,166,594 project grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "EARLY CARDIAC BIOMARKERS OF INFLAMMATION AND REMODELING IN DMD," will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The project will investigate innovative approaches to address critical health challenges related...